Inogen competitors

Crispin Teufel is a Board Member at Bellerophon Therapeutics; Chairman Of The Board at German American Chamber of Commerce of the Southern US, Inc.; and Chief Executive Officer at LINCARE HOLDINGS INC and is based in Washington, D.C.. He has worked as Head of IFRS Competence Center & External Reporting at Linde, Intern at Rosenfelt Christensen & West Engineering A/S, and Chief Financial Officer at LINCARE HOLDINGS INC. Crispin studied at University of Chicago Booth School of Business between 2018 and 2019; Saïd Business School, University of Oxford between 2009 and 2009; and Ministry of Finance State of Hessen between 2005 and 2005.

Tim Pigg is a Chief Executive Officer at Rotech Healthcare Inc.

Russ is a seasoned dental/medical device professional with over 30 years of experience. Most recently, he has transitioned into the consulting arena and presently serves as a Senior Executive Consultant with Cellerant Consulting Group. Prior to the consulting transition, Russ held executive leadership roles for nearly 20 years, having served as CEO of Keystone Dental Inc., Chief Commercial Officer and later President of Zest Dental Solutions, President of Henry Schein Orthodontics (HSO), and General Manager for Macropore Biosurgery. Before moving into leadership/C-suite roles, his career accomplishments have been focused in the marketing discipline holding positions in nearly every aspect of medical device marketing to include senior marketing management, all levels of product management, marketing research, and marketing communications. He held Vice-President of Global Marketing positions with Biomet 3i and Zimmer Dental prior to the merger of those organizations as well as senior marketing assignments with Stryker Leibinger and Macropore, Inc. Other employers have included Olympus Endoscopy and The American Red Cross. Russ has a B.S. with a concentration in marketing from the State University of New York at Plattsburgh where he graduated with Cum Laude honors and was voted \'The Most Outstanding Student\' in the marketing major. He earned an MBA at San Diego State University, graduating at the top of his class and completing a mini thesis on \'The Adoption and Diffusion of New Medical Technology\'. He has completed additional graduate level coursework and seminars at University of San Diego, UCLA, The University of Chicago, and Seton Hall University. His experience spans smaller start-ups as well as larger established medical device companies in public, privately-held, and private-equity sponsored environments.

Bart Doedens is a Senior Vice President at Zimmer Biomet Holdings Inc. and Chief Executive Officer at DDS LAB LLC and is based in Tampa, Florida. He has worked as President & CEO at Atlas Spine, President at Employment Background Investigations, and President at Biomet 3i. Bart attended Vrije Universiteit Amsterdam between 1977 and 1986 and Simon School of Business University of Rochester between 1990 and 1992.